Abstract:BACKGROUND:Vascular growth followed by vessel specification is crucial for the establishment of a hierarchical blood vascular network. We have shown that TIE2 is required for vein development while little is known about its homologue TIE1 (tyrosine kinase with immunoglobulin-like and EGF [epithelial growth factor]-like domains 1) in this process. METHODS:We analyzed functions of TIE1 as well as its synergy with TIE2 in the regulation of vein formation by employing genetic mouse models targeting Tie1, Tek, and Nr2f2, together with in vitro cultured endothelial cells to decipher the underlying mechanism. RESULTS:Cardinal vein growth appeared normal in TIE1-deficient mice, whereas TIE2 deficiency altered the identity of cardinal vein endothelial cells with the aberrant expression of DLL4 (delta-like canonical Notch ligand 4). Interestingly, the growth of cutaneous veins, which was initiated at approximately embryonic day 13.5, was retarded in mice lack of TIE1. TIE1 deficiency disrupted the venous integrity, displaying increased sprouting angiogenesis and vascular bleeding. Abnormal venous sprouts with defective arteriovenous alignment were also observed in the mesenteries of Tie1-deleted mice. Mechanistically, TIE1 deficiency resulted in the decreased expression of venous regulators including TIE2 and COUP-TFII (chicken ovalbumin upstream promoter transcription factor, encoded by Nr2f2, nuclear receptor subfamily 2 group F member 2) while angiogenic regulators were upregulated. The alteration of TIE2 level by TIE1 insufficiency was further confirmed by the siRNA-mediated knockdown of Tie1 in cultured endothelial cells. Interestingly, TIE2 insufficiency also reduced the expression of TIE1. Combining the endothelial deletion of Tie1 with 1 null allele of Tek resulted in a progressive increase of vein-associated angiogenesis leading to the formation of vascular tufts in retinas, whereas the loss of Tie1 alone produced a relatively mild venous defect. Furthermore, the induced deletion of endothelial Nr2f2 decreased both TIE1 and TIE2. CONCLUSIONS:Findings from this study imply that TIE1 and TIE2, together with COUP-TFII, act in a synergistic manner to restrict sprouting angiogenesis during the development of venous system.

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor

Dll4 and Notch signalling couples sprouting angiogenesis and artery formation

Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy with Its Homologue TIE2

Notch Signaling Regulates Vessel Structure and Function Via Hspg2.

S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress–dependent VEGF-C signaling

Notch Signaling in Vascular Smooth Muscle Regulates Angiogenesis

Notch regulates the angiogenic response via induction of VEGFR-1

Distinct Vascular Endothelial Growth Factor Signals for Lymphatic Vessel Enlargement and Sprouting.

Blocking of DLL4/Notch Signaling Deregulates Tumor Angiogenesis

Notch signaling in primary endothelial cells

Notch signaling regulates UNC5B to suppress endothelial proliferation, migration, junction activity, and retinal plexus branching

Inhibition of Endothelial Cell Proliferation by Notch1 Signaling is Mediated by Repressing MAPK and PI3K/Akt Pathways and Requires MAML1

Selective Regulation of Notch Ligands During Angiogenesis is Mediated by Vimentin

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

Neuropilin-2 Mediates VEGF-C–induced Lymphatic Sprouting Together with VEGFR3

A Snail1/Notch1 Signalling Axis Controls Embryonic Vascular Development.

Nrarp Coordinates Endothelial Notch and Wnt Signaling to Control Vessel Density in Angiogenesis

Recent Researches on the Notch Signaling Pathway

CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis

The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling

Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression